Ozgur Sahin
University of South Carolina
H-index: 33
North America-United States
Top articles of Ozgur Sahin
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Targeting TACC3 induces immunogenic cell death and enhances T-DM1 response in HER2-positive breast cancer | Cancer Research | Mustafa Emre Gedik Ozge Saatci Nathaniel Oberholtzer Meral Uner Ozge Akbulut-Caliskan | 2024/2/6 |
Transcriptome analysis of polyploid giant cancer cells and their progeny reveals a functional role for p21 in polyploidization and depolyploidization | Journal of Biological Chemistry | Shai White-Gilbertson Ping Lu Ozge Saatci Ozgur Sahin Joe R Delaney | 2024/4/1 |
Novel bi-thiazole LOX inhibitors to overcome chemotherapy resistance in triple negative breast cancer | Cancer Research | Metin Cetin Ozge Saatci Abdol-Hossein Rezaeian Ozge Akbulut Nageswara Rao Chintada | 2023/4/4 |
Inhibition of TACC3 blocks the growth of highly aggressive breast cancers with centrosome amplification | Cancer Research | Ozge Saatci Ozge Akbulut Metin Cetin Vitali Sikirzhytski Ozgur Sahin | 2023/4/4 |
Toxic PARP trapping upon cAMP-induced DNA damage reinstates the efficacy of endocrine therapy and CDK4/6 inhibitors in treatment-refractory ER+ breast cancer | Nature Communications | Ozge Saatci Metin Cetin Meral Uner Unal Metin Tokat Ioulia Chatzistamou | 2023/11/2 |
Overcoming tamoxifen resistance by re-activating cAMP-Ca2+−ROS-ferroptosis axis in ER+ breast cancer | Cancer Research | Rashedul Alam Ozge Saatci Meral Bugadyci Uner Kim-Tuyen Huynh-Dam Metin Cetin | 2023/4/4 |
Cholesterol biogenesis is a PTEN‐dependent actionable node for the treatment of endocrine therapy‐refractory cancers | Cancer Science | Irmak Kaysudu Taha Bugra Gungul Sena Atici Sevval Yilmaz Engin Bayram | 2023/11 |
Abstract P4-08-20: Inhibition of TACC3 blocks the growth of highly aggressive breast cancers with centrosome amplification | Cancer Research | Ozge Saatci Ozge Akbulut Metin Cetin Vitali Sikirzhytski Ozgur Sahin | 2023/3/1 |
Targeting TACC3 represents a novel vulnerability in highly aggressive breast cancers with centrosome amplification | Cell Death & Differentiation | Ozge Saatci Ozge Akbulut Metin Cetin Vitali Sikirzhytski Meral Uner | 2023/5 |
Abstract P6-10-18: Developing novel lysyl oxidase (LOX) inhibitors to overcome chemotherapy resistance in triple negative breast cancer | Cancer Research | Metin Cetin Ozge Saatci Ozge Akbulut Chad Beneker Abdol-Hossein Rezaeian | 2023/3/1 |
Highly potent TACC3 inhibitor as a novel anticancer drug candidate | 2023/4/11 | ||
Crosstalk between pro-survival sphingolipid metabolism and complement signaling induces inflammasome-mediated tumor metastasis | Cell reports | Alhaji H Janneh Mohamed Faisal Kassir F Cansu Atilgan Han Gyul Lee Megan Sheridan | 2022/12/6 |
miR-489 confines uncontrolled estrogen signaling through a negative feedback mechanism and regulates tamoxifen resistance in breast cancer | International Journal of Molecular Sciences | Mithil Soni Ozge Saatci Gourab Gupta Yogin Patel Manikanda Raja Keerthi Raja | 2022/7/22 |
Targeting HIF1-alpha/miR-326/ITGA5 axis potentiates chemotherapy response in triple-negative breast cancer | Breast cancer research and treatment | Ridho Assidicky Unal Metin Tokat Ibrahim Oguzhan Tarman Ozge Saatci Pelin Gulizar Ersan | 2022/6 |
HSP90 inhibitors induce GPNMB cell-surface expression by modulating lysosomal positioning and sensitize breast cancer cells to glembatumumab vedotin | Oncogene | Marco Biondini Alex Kiepas Leeanna El-Houjeiri Matthew G Annis Brian E Hsu | 2022/3/18 |
EGF-SNX3-EGFR axis drives tumor progression and metastasis in triple-negative breast cancers | Oncogene | Esra Cicek Ayca Circir Merve Oyken Ozge Akbulut Caliskan Didem Naz Dioken | 2022/1/5 |
Abstract LT015: Overcoming chemotherapy resistance in triple negative breast cancer via targeting lysyl oxidase (LOX) | Cancer Research | Ozge Saatci Ozge Akbulut Abdol-Hossein Rezaeain Carolyn Banister Vitali Sikirzhytski | 2021/3/1 |
Coordinated regulation of WNT/β-catenin, c-Met, and integrin signalling pathways by miR-193b controls triple negative breast cancer metastatic traits | BMC cancer | Chiara Giacomelli Janine Jung Astrid Wachter Susanne Ibing Rainer Will | 2021/12 |
Thymidylate synthase drives the phenotypes of epithelial-to-mesenchymal transition in non-small cell lung cancer | British journal of cancer | Mohammad Aarif Siddiqui Paradesi Naidu Gollavilli Vignesh Ramesh Beatrice Parma Annemarie Schwab | 2021/1/5 |
Endocrine resistance in breast cancer: from molecular mechanisms to therapeutic strategies | Ozge Saatci Kim-Tuyen Huynh-Dam Ozgur Sahin | 2021/12 |
